Group 1 - The core viewpoint of the article highlights the significant performance of the China Securities Hong Kong 100 Healthcare Index, which has seen a remarkable increase of 21.00% in the past month, 52.68% in the past three months, and 95.84% year-to-date [1] - The index is categorized based on the China Securities industry classification standards, with a base date of December 31, 2004, and a base point of 1000.0 [1] - The index is fully composed of securities listed on the Hong Kong Stock Exchange, with the chemical drugs sector accounting for 54.75%, biopharmaceuticals for 18.73%, pharmaceutical and biotechnology services for 14.45%, and medical commerce and services for 12.07% [1] Group 2 - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with provisions for temporary adjustments under special circumstances [2] - Adjustments to the index samples occur in response to changes in the parent index, special events affecting industry classification, or the delisting of sample companies [2]

Core Viewpoint - The China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a year-to-date increase of 89.44% and a recent one-month increase of 20.84% [1]. Group 1: Index Performance - The China Securities Hong Kong 100 Pharmaceutical and Health Index reported a value of 1095.17 points [1]. - The index has increased by 44.95% over the past three months [1]. - The index is based on a sample of securities classified according to the China Securities industry classification standards, with a base date of December 31, 2004, set at 1000.0 points [1]. Group 2: Index Composition - The index is fully composed of securities listed on the Hong Kong Stock Exchange, with a 100.00% allocation [1]. - The composition by industry includes: - Chemical drugs: 55.11% - Biological drugs: 18.62% - Pharmaceutical and biotechnology services: 14.56% - Medical commerce and services: 11.71% [1]. Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]. - Adjustments occur in response to changes in the parent index, special events affecting industry classification, or the delisting of sample companies [2].

Core Viewpoint - The China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a 22.21% increase over the past month, 41.09% over the past three months, and a remarkable 96.31% year-to-date [1]. Group 1: Index Performance - The China Securities Hong Kong 100 Pharmaceutical and Health Index is currently at 1134.87 points [1]. - The index is classified based on the China Securities Industry Classification Standard, with a base date of December 31, 2004, set at 1000.0 points [1]. Group 2: Market Composition - The index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100.00% allocation [1]. - The industry composition of the index includes: - Chemical drugs: 54.47% - Biological drugs: 19.42% - Pharmaceutical and biotechnology services: 14.91% - Medical commerce and services: 11.20% [1]. Group 3: Index Adjustment Mechanism - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with provisions for temporary adjustments under special circumstances [2].

Group 1 - The core viewpoint of the news is that the China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a year-to-date increase of 90.32% [1] - The index has risen by 18.48% in the past month and 36.79% in the last three months, indicating strong performance in the pharmaceutical sector [1] - The index is composed entirely of securities listed on the Hong Kong Stock Exchange, with a base date of December 31, 2004, and a base point of 1000.0 [1] Group 2 - The index sample is adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, but can be temporarily modified under special circumstances [2] - Adjustments to the index sample occur in response to events such as delistings, mergers, or changes in industry classification [2]